Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia

Blood. 1994 May 1;83(9):2749-50.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anemia, Aplastic / therapy*
  • Bone Marrow Transplantation*
  • Cyclosporine / administration & dosage
  • Cyclosporine / therapeutic use*
  • Graft vs Host Disease / prevention & control*
  • Humans
  • Methotrexate / administration & dosage
  • Methotrexate / therapeutic use*
  • Prospective Studies

Substances

  • Cyclosporine
  • Methotrexate